Health News

Watson Pharmaceuticals, Inc.(NYSE: WPI), announced that it intends to launch ella(R) (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson’s announcement follows the approval of ella(R) by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours - or five days - post-unprotected intercourse (UPI) or contraceptive failure…

Read more

Filed under: Pharmacy News
Tags: Pharmacy, Pregnancy

Related posts

• Watson launches Generess Fe low-dose oral contraceptives in the U.S. (0)
  Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods. Read more [tags] Pharmacy News [/tags]
  
  
• Viagra promotes fetal growth in pregnant sheep, raises hope for preventing fetal development problems in humans (0)
  A joke among two Texas AgriLife Research scientists later turned into a fully-funded study found Viagra can aid fetal development in female sheep. Female sheep (ewes) are an agriculturally important species, which can serve as an excellent animal model for studying the physiology of human pregnancy, the researchers said. Read more [tags] Pharmacy News [/tags]
  
  
• Valproate exposure during pregnancy can impair a child’s cognitive development (0)
  Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found. Read more [tags] Pharmacy News [/tags]
  
  
• Using mild painkillers during pregnancy can increase risk of male reproductive disorders (0)
  New evidence has emerged that the use of mild painkillers such as paracetamol, aspirin and ibuprofen, may be part of the reason for the increase in male reproductive disorders in recent decades. Read more [tags] Pharmacy News [/tags]
  
  
• Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women (0)
  The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ. Read more [tags] Pharmacy News [/tags]